Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 21.47

(6.93%)

Total Assets Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual total assets in 2023 was 5.41 Billion CNY , up 2.4% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly total assets in 2024 Q2 was 5.3 Billion CNY , down -1.06% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported annual total assets of 5.28 Billion CNY in 2022, up 4.99% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported annual total assets of 5.03 Billion CNY in 2021, up 3.15% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported quarterly total assets of 5.36 Billion CNY for 2024 Q1, down -0.84% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported quarterly total assets of 5.3 Billion CNY for 2024 Q2, down -1.06% from previous quarter.

Annual Total Assets Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1992)

Historical Annual Total Assets of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1992)

Year Total Assets Total Assets Growth
2023 5.41 Billion CNY 2.4%
2022 5.28 Billion CNY 4.99%
2021 5.03 Billion CNY 3.15%
2020 4.87 Billion CNY -0.18%
2019 4.88 Billion CNY 10.02%
2018 4.44 Billion CNY 48.12%
2017 2.99 Billion CNY -0.12%
2016 3 Billion CNY 6.66%
2015 2.81 Billion CNY 16.52%
2014 2.41 Billion CNY 62.76%
2013 1.48 Billion CNY 20.39%
2012 1.23 Billion CNY 45.53%
2011 847.55 Million CNY 9.83%
2010 771.68 Million CNY 10.25%
2009 699.94 Million CNY 7.4%
2008 651.74 Million CNY 10.72%
2007 588.65 Million CNY 1.6%
2006 579.39 Million CNY 18.78%
2005 487.8 Million CNY -12.72%
2004 558.9 Million CNY -12.13%
2003 636.08 Million CNY 12.1%
2002 567.41 Million CNY -27.38%
2001 781.36 Million CNY 15.19%
2000 678.35 Million CNY 2.88%
1999 659.36 Million CNY -2.05%
1998 673.15 Million CNY 10.99%
1997 606.51 Million CNY 40.65%
1996 431.22 Million CNY 8.89%
1995 396.02 Million CNY 40.93%
1994 281.01 Million CNY 54.3%
1993 182.12 Million CNY 52.56%
1992 119.38 Million CNY 0.0%

Peer Total Assets Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 61.86%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 4.32 Billion CNY -25.064%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 21.262%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 62.381%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY -83.338%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 77.568%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 65.566%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY -85.292%
Pulike Biological Engineering, Inc. 3.26 Billion CNY -65.88%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY -43.127%
Shanghai Hile Bio-Technology Co., Ltd. 1.65 Billion CNY -226.428%
Qingdao Vland Biotech INC. 3.03 Billion CNY -78.354%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY -70.471%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY -110.182%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY -61.855%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY -76.81%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY -21.466%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY -51.979%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 6.532%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY -52.551%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -235.798%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -239.484%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 5.827%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY -78.528%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 52.293%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY -170.87%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY -87.425%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY -129.676%
Novogene Co., Ltd. 3.59 Billion CNY -50.549%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY -32.82%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -235.566%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY -2.004%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 23.843%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY -38.525%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY -209.828%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY -61.69%
Sinocelltech Group Limited 2.71 Billion CNY -99.054%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY -15.844%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY -23.646%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY -36.298%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 8.457%
Jiangsu gdk Biotechnology Co., Ltd. 1.63 Billion CNY -231.659%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY -121.033%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY -109.777%